Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Steffen

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Journal of Central Nervous System Disease|December 9, 2021
Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tabletsChristoph Grothe, Falk Steffen, Stefan Bittner
Neurology(R) Neuroimmunology & Neuroinflammation|November 12, 2021
Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple SclerosisMarkus Bock, Falk Steffen, Frauke Zipp, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 14, 2020
Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurementKatrin Pape, Falk Steffen, Frauke Zipp, et al.
Med (New York, N.Y.)|May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosisAaron Schuckmann, Falk Steffen, Frauke Zipp, et al.
Frontiers in Neurology|November 6, 2020
Stroke Care Within the COVID-19 Pandemic-Increasing Awareness of Transient and Mild Stroke Symptoms NeededTimo Uphaus, Sonja Gröschel, Eyad Hayani, et al.
Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2020
Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MSSinah Engel, Falk Steffen, Timo Uphaus, et al.
European Journal of Neurology|February 8, 2021
Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody-positive autoimmune encephalitis under immune checkpoint inhibitor therapyJohannes Piepgras, Aneka Müller, Falk Steffen, et al.
Med (New York, N.Y.)|November 8, 2024
Recurrent late-onset neutropenia following treatment with different B cell-depleting strategies in multiple sclerosisMaria Protopapa, Muriel Schraad, Katrin Pape, et al.
Fluids and Barriers of the CNS|January 11, 2023
Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertensionSinah Engel, Johannes Halcour, Erik Ellwardt, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Journal of Central Nervous System Disease|December 9, 2021
Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tabletsChristoph Grothe, Falk Steffen, Stefan Bittner
Neurology(R) Neuroimmunology & Neuroinflammation|November 12, 2021
Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple SclerosisMarkus Bock, Falk Steffen, Frauke Zipp, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 14, 2020
Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurementKatrin Pape, Falk Steffen, Frauke Zipp, et al.
Med (New York, N.Y.)|May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosisAaron Schuckmann, Falk Steffen, Frauke Zipp, et al.
Frontiers in Neurology|November 6, 2020
Stroke Care Within the COVID-19 Pandemic-Increasing Awareness of Transient and Mild Stroke Symptoms NeededTimo Uphaus, Sonja Gröschel, Eyad Hayani, et al.
Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2020
Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MSSinah Engel, Falk Steffen, Timo Uphaus, et al.
European Journal of Neurology|February 8, 2021
Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody-positive autoimmune encephalitis under immune checkpoint inhibitor therapyJohannes Piepgras, Aneka Müller, Falk Steffen, et al.
Med (New York, N.Y.)|November 8, 2024
Recurrent late-onset neutropenia following treatment with different B cell-depleting strategies in multiple sclerosisMaria Protopapa, Muriel Schraad, Katrin Pape, et al.
Fluids and Barriers of the CNS|January 11, 2023
Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertensionSinah Engel, Johannes Halcour, Erik Ellwardt, et al.
Pageof 6